ObsEva: Linzagolix Gets Positive CHMP Opinion For Uterine Fibroids - Quick Facts
17/12 07:28
(RTTNews) - ObsEva SA (OBSV), a Swiss biopharma company focused on women's reproductive health, Friday said Linzagolix, an Oral GnRH Antagonist, received positive opinion recommending approval from the Committee for Medicinal Products for Human Use or CHMP of the European Medicin...